Invited Speaker at International Meetings

• 19th European Workshop on Drug Metabolism. Bi-annual conference sponsored by the European Society of Biochemical Pharmacology. Roberta S. King, Bioactivation and Detoxification of the Dietary Carcinogen 2-Amino-a-carboline: Similarities and Differences from Other Heterocyclic Aromatic Amines, October 5, 2004, Antalya, Turkey.
   

• International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-1), European Federation for Medicinal Chemistry. Roberta S. King, Inhibition of human sulfotransferases by NSAIDs. September 25-28, 2002, Gazi University, Ankara, Turkey.
   

• The 8th International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds, Roberta S. King,  In vivo metabolism of 2-amino-a-carboline (AaC), November 12-14, 2001, Washington, DC. Award for Outstanding Contribution to Original Research.

Published Abstracts (since 1999) (* denotes presenting author)

• *King RS and Yuan Z (2004) Novel metabolites of 2-amino-a-carboline (AaC) formed in rats in vivo, rat hepatocytes, and HepG2 cells. Chemical Research In Toxicology 17(12):1776. (The 228^th American Chemical Society National Meeting, Philadelphia, PA, August 22-26, 2004).
   

• *Chichester CO, MacDonnell CP, King RS and Needham TE (2003) Utilization of Pharmacy Students for Evaluation of On-Line Health Information. AACP: 104:NIL94. (American Association of Colleges of Pharmacy Meeting, July 2003, Minneapolis, MN.)
   

• *King RS, Jha G, Churchwell MI, Doerge DR (2002) Metabolism of the heterocyclic amine 2-amino-alpha-carboline. Drug Metabolism Reviews 34(S1):190. (The 11^th North American International Society for the Study of Xenobiotics (ISSX) Meeting, October 27-31, 2002, Orlando, FL.)
   

• *King RS and Ghosh A (2001) Inhibition of human sulfotransferase SULT1A1 by certain NSAIDS. Drug Metabolism Reviews 33(S1):260. (The 6^th International ISSX Meeting, October 7-11, 2001, Munich, Germany.)
   

• *Ghosh AA and King RS (2000) Molecular specificity and mechanism of the inhibition of SULT1A1, NAT1, and NAT2 by certain non-steroidal anti-inflammatory drugs. Drug Metabolism Reviews 32(S2):192. (The 10^th North American ISSX Meeting, October 24-28, 2000, Indianapolis, IN).

Additional presentations at International Meetings (since 1999)

• Zhixin Yuan, Gautam Jha, and *Roberta S. King, Novel Metabolites of 2-Amino-a-carboline Formed In Vivo in Rats, Rat Hepatocytes, and HepG2 Cells. The 19^th European Workshop on Drug Metabolism, Antalya, Turkey, October 3-6, 2004.
   

• *King RS, Jha G, Churchwell MI, Doerge DR (2002) Metabolism of the heterocyclic amine carcinogen 2-amino-alpha-carboline. New England Drug Metabolism Discussion Group Summer Symposium, June 12, 2002, Shrewsbury, MA.
   

• *Jha G and King RS (2001), In vivo metabolism of 2-amino-a-carboline (AaC). The 8th International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds, Washington, DC, November 12-14, 2001. Best abstract award.
   

• *King RS and Ghosh A (2001) Inhibition of human sulfotransferase SULT1A1 by certain NSAIDs. Poster presented at The 31^st Gordon Research Conference on Drug Metabolism, Holderness School, Plymouth NH, July 8-13, 2001.
   

• *King RS, Sharma V, and Duffel MW (2000) Structure-function modeling of the interactions of N‑alkyl-N-hydroxyanilines with rat hepatic aryl sulfotransferase IV. Poster presented at The 30^th Gordon Research Conference on Drug Metabolism, Holderness School, Plymouth NH, July 9-14, 2000.

Student Presentations at Regional or Local Meetings

• Gautam Jha and Roberta S. King (2001) In vivo metabolism of 2-amino-alpha-carboline. The 30th Annual New England Pharmacologists (NEP) Meeting, January 26-27, 2001, Newport, RI.
   

• Anasuya Ghosh and Roberta S. King (2001) Inhibition of SULT1A1, NAT1, and NAT2 by certain non-steroidal anti-inflammatory drugs. The 30th Annual New England Pharmacologists (NEP) Meeting, January 26-27, 2001, Newport, RI.
   

• Gautam Jha and Roberta S. King (2001) In vivo metabolism of 2-amino-alpha-carboline. New England Regional Medicinal Chemistry and Pharmacognosy (NERMCAP) Meeting, June 15-16, 2001, Boston MA.
   

• Zhixin Yuan and Roberta S. King (2003) New England Regional Medicinal Chemistry and Pharmacognosy (NERMCAP) Meeting, 2003, Kingston, RI.
   

• Danielle Savastano and Roberta S. King (2003) Preparation and assay of SULT1A1 from transfected e. coli XL-Blue cultures. RI-BRIN Summer Undergraduate Program Research Day, University of Rhode Island, August, 2003.
   

• Zubia Alam, JinFang Wu, and Roberta S. King (2004) Methods to study in vitro and intracellular estradiol metabolism. RI-BRIN Summer Undergraduate Program Research Day, University of Rhode Island, August, 2004.
   

• Mike Cipriano and Roberta S. King (2005) Effect of estrogen sulfotransferase inhibitors on proliferation of MCF-7 human breast cancer cells. RI-INBRE Summer Undergraduate Program Research Day, University of Rhode Island, August 17, 2005.
   

• Viviana Castano and Roberta S. King (2005) Effect of estrogen sulfotransferase inhibitors on estradiol concentration in MCF-7 human breast tumor cells. RI-INBRE Summer Undergraduate Program Research Day, University of Rhode Island, August 17, 2005.

© University
of Rhode Island
Disclaimer

The University is an affirmative action/equal opportunity employer.
All rights reserved